Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

At ECTRIMS 2024, the assistant professor at the University of Naples the latest multiple sclerosis diagnostic criteria, which emphasized a shift toward biologically based diagnoses. [WATCH TIME: 4 minutes]

Bridging Clinical Signs and Biological Evidence to Transform MS Diagnosis: Marcello Moccia, MD, PhD

Articles

A new study highlighted the importance of initiating immunotherapy promptly in chronic inflammatory demyelinating polyneuropathy to prevent axonal damage and disability progression.

Early Immunotherapy May Be Crucial to Prevent Axonal Damage in CIDP, Study Suggests

At the 2024 ECTRIMS Congress, the neurologist at the University Hospital Center of Nice talked about how the decision to treat patients at risk of MS is highly individualized. [WATCH TIME: 3 minutes]

Navigating the Decision to Treat Multiple Sclerosis Early Versus Later: Mikael Cohen, MD

Here's some of what is coming soon to NeurologyLive® this week. 

This Week on NeurologyLive® — January 20, 2024

The neurologist and sleep disorder specialist at Allegheny Health Network discussed the challenges with preventing narcolepsy and the strategies patients can take to improve their overall prognosis. [WATCH TIME: 4 minutes]

Curving Complications Associated With Narcolepsy: Mihaela Nowak, MD

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

The professor and chair of the Department of Molecular Pathobiology at NYU College of Dentistry discussed groundbreaking research on chronic pain, focusing on the discovery of new mechanisms involving nerve growth factor and its receptors.

NeuroVoices: Nigel Bunnett, PhD, BSc, on Identifying a Novel Therapeutic Target for Chronic Pain

Founding director of the Optimal Aging Institute at the NYU Grossman School of Medicine.

The founding director of the Optimal Aging Institute at the NYU Grossman School of Medicine talked about a recent study that estimated the lifetime risk of dementia and its implications for prevention, care, as well as societal planning. [WATCH TIME: 5 minutes]

Understanding Lifetime Risk and the Rising Burden of Dementia: Josef Coresh, MD, PhD

James Wheless, MD, FAAP, FAAN, FAES, Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center, shared insights on his presentation from AES 2024, focusing on stiripentol, an FDA-approved treatment for Dravet syndrome.

Optimizing Epilepsy Treatments: Stiripentol’s Role in Dravet Syndrome

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AES 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Updates in the Management of Relapsing Multiple Sclerosis

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis 

Use of MRI in Diagnosing Multiple Sclerosis 

Misdiagnosis of Multiple Sclerosis

Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

Challenges in Optimally Treating Multiple Sclerosis

 QoL Issues in the Management of Multiple Sclerosis

Multiple Sclerosis Fatigue

TRIUMPHANT-MS Trial: Fatigue in MS

OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

Strategies for Choosing Initial Therapy in MS

Anti-CD20 Monoclonal Antibodies for Treatment of RMS

Cladribine for Treatment of RMS

S1P Receptor Modulators for Treatment of RMS

Fumarates for Treatment of RMS

The Future of Managing Multiple Sclerosis

Peer Exchange

Clinical

EMD-22-NRD0193 - /clinical/multiple-sclerosis

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Fumarates for Treatment of RMS

EP: 1.2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

EP: 2.Use of MRI in Diagnosing Multiple Sclerosis

EP: 3.Misdiagnosis of Multiple Sclerosis

EP: 4.Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

EP: 5.Challenges in Optimally Treating Multiple Sclerosis

EP: 6. QoL Issues in the Management of Multiple Sclerosis

EP: 7.Multiple Sclerosis Fatigue

EP: 8.TRIUMPHANT-MS Trial: Fatigue in MS

EP: 9.OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

EP: 10.Strategies for Choosing Initial Therapy in MS

EP: 11.Anti-CD20 Monoclonal Antibodies for Treatment of RMS

EP: 12.Cladribine for Treatment of RMS

EP: 13.S1P Receptor Modulators for Treatment of RMS

EP: 14.Fumarates for Treatment of RMS

EP: 15.The Future of Managing Multiple Sclerosis